Literature DB >> 28315512

Comments to: Clinical experience of switching anti-VEGF therapy from ranibizumab to aflibercept in age-related choroidal neovascularization.

Dan Călugăru1, Mihai Călugăru1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28315512     DOI： 10.5301/ejo.5000949

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN： 1120-6721            Impact factor:   2.597


× No keyword cloud information.
  1 in total

1.  Effects of photodynamic therapy plus intravitreal aflibercept with subtenon triamcinolone injections for aflibercept-resistant polypoidal choroidal vasculopathy.

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-09-06       Impact factor: 3.117
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.